ctDNA-driven Adaptive Proton Craniospinal Irradiation in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis After Resistance to Third-Generation TKIs in the Consolidation Phase

​ Conditions: Leptomeningeal Metastasis From Lung Cancer

Interventions: Radiation: proton craniospinal irradiation; Drug: Intrathecal pemetrexed

Sponsors: Shuanghu Yuan

Recruiting Conditions: Leptomeningeal Metastasis From Lung Cancer
Interventions: Radiation: proton craniospinal irradiation; Drug: Intrathecal pemetrexed
Sponsors: Shuanghu Yuan
Recruiting